Preventing cervical cancer in women living with HIV in central Kenya
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
Offers screening and same-day treatment to help prevent cervical cancer in women living with HIV at local clinics in central Kenya.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kenya Medical Research Institute (Kemri) NIH-funded |
| Lab location | 1 site (Nairobi City, Kenya) |
| Project ID | NIH-11118696 on NIH RePORTER |
What this research studies
If you are a woman living with HIV and attend care at the participating clinics, you may be offered cervical cancer screening as part of your routine visits. The clinics use a screen-and-treat approach where abnormal findings can often be treated the same day using a thermal ablation device. The work is run by KEMRI in partnership with local HIV programs and builds on an ongoing implementation effort called TIBA. Participation may include the screening procedure, a brief outpatient treatment if needed, and follow-up visits.
Who could benefit from this research
Good fit: Women living with HIV who receive care at the participating public hospitals in Kiambu County (Thika, Ruiru, Igegania) and are eligible for cervical cancer screening.
Not a fit: Women not living with HIV, not receiving care at the listed clinics, already diagnosed with invasive cervical cancer, or with medical reasons preventing screening or thermal ablation may not benefit from this program.
Why it matters
Potential benefit: This could reduce cervical cancer cases and deaths by finding and treating precancer early among women living with HIV.
How similar studies have performed: Screen-and-treat approaches with single-visit thermal ablation have shown promise in similar low-resource settings and are being used in related projects like the TIBA implementation study.
Where this research is happening
Nairobi City, Kenya
- Kenya Medical Research Institute (Kemri) — Nairobi City, Kenya (Active)
Researchers
- Principal investigator: Mugo, Nelly Rwamba — Kenya Medical Research Institute (Kemri)
- Study coordinator: Mugo, Nelly Rwamba
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.